Drug-labels.com

Mylan-Glybe: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
5 mg, 2.5 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Mylan-Glybe

ABOUT THIS MEDICATION

ABOUT THIS MEDICATION

What the medication is used for:

MYLAN-GLYBE (glyburide) is used as an adjunct to proper diet, exercise and weight reduction to lower blood glucose in adult patients with type 2 diabetes mellitus.

What it does:

MYLAN-GLYBE lowers blood sugar by stimulating the pancreas to secrete insulin. The pancreas must produce insulin for this medication to work.

People with type 2 diabetes are not able to make enough insulin or respond normally to the insulin their bodies make. When this happens, sugar (glucose) builds up in the blood. This can lead to serious medical problems including kidney damage, amputations, and blindness. Diabetes is also closely linked to heart disease. The main goal of treating diabetes is to lower your blood sugar to a normal level and by doing so can prevent long term complications.

In addition to taking MYLAN-GLYBE, you should continue to exercise and follow the diet recommended for you by your doctor.

When it should not be used:

Do not take MYLAN-GLYBE

  • If you have Type 1 diabetes.
  • If you have known hypersensitivity or allergy to this drug, any sulfonylurea or sulfonamides, or to any ingredient in the formulation or component of the container.
  • If you have diabetic ketoacidosis (an emergency condition with high blood glucose levels, a lack of insulin and an accumulation of ketones (chemicals) in the blood and urine). This condition should be treated with insulin.
  • Diabetic precoma or coma.
  • During stress conditions such as severe infections, trauma or surgery.
  • In the presence of liver disease or frank jaundice; or kidney disease.
  • If you are being treated with bosentan.

    • If you are pregnant or breastfeeding.

What the medicinal ingredient is:

The medicinal ingredient for MYLAN-GLYBE is glyburide.

What the important nonmedicinal ingredients are:

MYLAN-GLYBE tablets contain the following non-medicinal ingredients: colloidal anhydrous silica, lactose monohydrate, magnesium stearate, starch (corn starch and pre-gelatinized corn starch) and talc.

What dosage forms it comes in:

Tablets. Each tablet contains 2.5 mg or 5.0 mg glyburide.

WARNINGS AND PRECAUTIONS

Proper diet, exercise and weight reduction are important to help you control your diabetes.

Your blood glucose may change in some situations, for example if you are stressed or suffering from other illnesses (e.g. infections). At such times, your doctor may need to modify your dose.

MYLAN-GLYBE may cause low blood sugar (hypoglycemia). , especially if you miss a meal, exercise for a long time, drink alcohol or use another antidiabetic medication with MYLAN-GLYBE.

Elderly patients may be more likely to experience low blood sugar with MYLAN-GLYBE.

If your blood sugar gets too low, you may feel shaky, weak, drowsy, confused, or very hungry. You may sweat or have blurred vision, abnormal heartbeats, trouble concentrating, or a headache that doesn't go away. Signs of severe hypoglycemia can include disorientation, loss of consciousness, and seizures.

You should ask your doctor, pharmacist or diabetes educator about symptoms of low blood sugar and what to do if you experience these symptoms. Teach your friends, co-workers, or family members what they can do to help you if you have low blood sugar.

You should also test your blood sugar as instructed by your doctor.

Before you use MYLAN-GLYBE talk to your doctor or pharmacist if:

  • You have or have had liver, kidney, or heart

    disease;

IMPORTANT: PLEASE READ

  • •
  • You are pregnant or planning to get pregnant;
  • You are breast-feeding.
  • You have a blood disease called G6PD-deficiency

    anemia.

  • You have a heart disease.

MYLAN-GLYBE is not recommended for use in children under 18 years of age.

Driving and Operating Machinery:

Alertness and reactions may be impaired due to low or high blood sugar (hypo- or hyperglycemia), especially when beginning or after changing treatment or when MYLAN-GLYBE is not taken regularly. This may affect your ability to drive or to operate machinery.

INTERACTIONS WITH THIS MEDICATION

Ask your doctor or pharmacist before taking any other medicine, including over-the-counter products.

Drugs that can interact with MYLAN-GLYBE include: diuretics (water pills), corticosteroids (such as prednisone), ACE inhibitors (a drug used to treat high blood pressure (hypertension)), birth control pills, and some kinds of cold and allergy drugs.

Avoid drinking alcohol while you are taking MYLAN-GLYBE.

PROPER USE OF THIS MEDICATION

Usual dose:

Take MYLAN-GLYBE exactly as prescribed by your doctor.

The usual dose is 2.5 to 10 mg daily. Maximum daily dose is 20 mg.

A dose of more than 10 mg should be taken in two divided doses.

Tablets should be taken during or immediately after meals.

Overdose:

Overdosage with this medication may result in hypoglycemia.

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you forget to take MYLAN-GLYBE tablets, do not take a double dose to make up for forgotten individual doses.

Discuss with your healthcare for dealing with such mistakes (in particular forgetting a dose or skipping a meal) or in the event a dose cannot be taken at the prescribed time.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Side effects:

As with any type of medication, glyburide is associated with some side effects.

The most common side effect of glyburide is low blood sugar (hypoglycemia). Please see the WARNINGS and PRECAUTIONS section above.

The following side effects have been observed with glyburide use: nausea, heartburn, feeling “full”, vomiting, diarrhea and abdominal pain.

Allergic skin reactions (itchiness, rash, eruption) have been reported in a number of patients. An increased sensibility to light has been associated with the use of oral antidiabetic drugs.

Transient visual disturbances may occur at the beginning of the treatment due to variations in level of blood sugar.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom/ EffectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
Common

Low blood sugar

(hypoglycemia)

√
UncommonSkin reactions (itchiness, rash, eruption)√
Rare

Blood

disorders (unusual

bruising or bleeding)

√
Very rareLiver problem (yellowing of the eyes or skin)√

Allergic

reaction

(difficult breathing, decreased blood pressure)

√

This is not a complete list of side effects. For any unexpected effects while taking MYLAN-GLYBE, contact your doctor or pharmacist.

IMPORTANT: PLEASE READ

HOW TO STORE IT

MYLAN-GLYBE should be stored between 15-30°C, and not beyond the expiry date indicated on the package.

Reporting Side Effects

You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information.

3 ways to report:

  • Online at MedEffet;
  • By calling 1-866-234-2345 (toll-free);
  • By completing a Consumer Side Effect Reporting Form and sending it by:

    • Fax to 1-866-678-6789 (toll-free), or
    • Mail to: Canada Vigilance Program

      Health Canada, Postal Locator 0701E Ottawa, ON

      K1A 0K9

Postage paid labels and the Consumer Side Effect Reporting Form are available at MedEffet.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document can be found at: www.mylan.ca.

The full Product Monograph prepared for health professionals can be obtained by contacting the sponsor, Mylan Pharmaceuticals ULC at: 1-800-575-1379

Etobicoke, Ontario M8Z 2S6

Revised on: January 11, 2016

Mylan Pharmaceuticals ULC Etobicoke, ON M8Z 2S6 1-800-575-1379 www.mylan.ca

IMPORTANT: PLEASE READ

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00808741

Revision date stated in the text: January 11, 2016

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mylan-Glybe

Rx or OTC
Prescription (Rx)?
DIN 00808741, 00808733
Schedule(s) PRESCRIPTION
Active ingredient(s) Glyburide
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A10 Drugs used in diabetes
      1. A10B Blood glucose lowering drugs, excl. insulins
        1. A10BB Sulfonylureas for blood glucose lowering
          1. A10BB01 Glibenclamide
Company MYLAN PHARMACEUTICALS ULC
Current status Cancelled Post Market
Current status date January 11, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
00808741 5 MG Tablet Cancelled Post Market January 11, 2017
00808733 2.5 MG Tablet Cancelled Post Market January 11, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.